Watching someone you love struggle with depression, anxiety, post-traumatic stress disorder (PTSD), or another neurological or psychiatric condition can be incredibly difficult, especially when they aren’t ready to seek help.
Sometimes the hesitation comes from discouragement after trying medications or therapy without meaningful improvement.
Other times it’s fear of the unknown, concerns about side effects, or simply feeling exhausted by the idea of trying yet another treatment.
At Neurotherapeutix, fMRI-guided TMS therapy offers a different approach.
Rather than relying solely on standardized treatment protocols, our clinicians use patented computational brain mapping to better understand how an individual’s brain networks communicate before treatment begins. For many families, knowing that treatment is personalized—not one-size-fits-all—can make the conversation feel less overwhelming.
If someone you care about has been reluctant to seek treatment, understanding this approach may help you support them with empathy, information, and hope.
Understanding why a loved one might resist treatment
When someone refuses treatment, it’s easy to assume they simply don’t want help.
In reality, reluctance often comes from a much more complicated place.
Some people have spent years trying medications, psychotherapy, or other interventions without experiencing the improvement they hoped for.
Others worry about being judged, feel discouraged after previous setbacks, or believe nothing will make a meaningful difference.
Mental health conditions themselves can also make it harder to seek care:
- Depression may reduce motivation and make even simple decisions feel overwhelming.
- Anxiety can amplify fears about starting something unfamiliar.
- PTSD may lead someone to avoid situations that feel emotionally vulnerable.
According to the National Institute of Mental Health, depression can affect how a person thinks, feels, and manages daily activities, making it difficult to seek help even when support is available.
Recognizing these barriers doesn’t solve them overnight, but it can change how families approach the conversation. Rather than viewing hesitation as resistance, it can help to see it as uncertainty, discouragement, or fear rooted in previous experiences.
That understanding creates space for a different discussion—one focused on exploring options instead of convincing someone to accept treatment.
Why a personalized approach may feel different
For many people, the idea of trying another treatment feels discouraging because previous approaches haven’t provided lasting improvement.
That’s one reason Neurotherapeutix takes a different approach.
Rather than beginning with a standardized treatment location, our clinicians first evaluate how an individual’s brain functions using brain mapping technology, which combines resting-state functional MRI (rsfMRI) with patented computational brain mapping.
This advanced imaging evaluates functional connectivity—the communication patterns between different brain networks involved in mood, attention, memory, emotional regulation, and other important functions.
Instead of assuming every patient with the same diagnosis should receive identical treatment, our team develops a personalized treatment plan based on each person’s symptoms, medical history, treatment goals, and unique brain connectivity.
For many families, this individualized approach feels different because it begins with understanding the person rather than simply applying the same protocol used for every patient.
It’s also important to remember that learning more about treatment doesn’t obligate anyone to begin therapy. An evaluation is simply an opportunity to gather information, ask questions, and determine whether this personalized approach may be appropriate.
How computational brain mapping works, step by step
One of the biggest sources of hesitation is simply not knowing what to expect. Understanding the process can help reduce some of that uncertainty and make the first conversation about treatment feel less intimidating.
The brain scan
Every patient’s journey begins with a comprehensive clinical evaluation.
During this appointment, the clinical team reviews symptoms, medical history, previous treatments, medications, and treatment goals.
When clinically appropriate, resting-state functional MRI is performed to evaluate how different brain regions communicate while the brain is at rest.
Unlike a traditional MRI, which produces images of the brain’s anatomy, rsfMRI measures functional connectivity to provide additional insight into how the brain’s networks function together.
Personalized treatment planning
After imaging is completed, the functional connectivity data is analyzed using Neurotherapeutix’s patented computational brain mapping technology.
Rather than relying solely on generalized anatomical landmarks, clinicians combine this information with the patient’s psychiatric evaluation, symptoms, medical history, and treatment goals to develop an individualized treatment plan.
Every recommendation is made on a case-by-case basis because no two brains—or treatment journeys—are exactly alike.
Non-invasive TMS therapy sessions
If treatment is recommended, patients receive TMS therapy in Manhattan according to their individualized treatment plan.
Because TMS therapy is non-invasive, patients remain awake throughout treatment and can typically return to many normal daily activities afterward.
Unlike procedures that require anesthesia or sedation, most individuals can drive themselves to and from appointments unless their physician recommends otherwise.
Throughout treatment, the clinical team continues monitoring progress, symptoms, and overall well-being while making recommendations based on each patient’s individual response.
Conditions where this approach may help
Every person’s experience is unique, and eligibility for treatment is determined through a comprehensive clinical evaluation. However, computational brain mapping and fMRI-guided TMS therapy may be considered for a variety of neurological and psychiatric conditions when clinically appropriate.
Depression
Many families begin exploring new options after watching a loved one struggle with depression despite previous treatment.
TMS therapy is FDA-cleared for the treatment of major depressive disorder in appropriate patients, and Neurotherapeutix combines this established therapy with patented computational brain mapping to personalize treatment planning based on each individual’s unique brain connectivity.
Anxiety
For individuals living with anxiety, brain networks involved in emotional regulation and stress responses may function differently from one person to another. Personalized treatment planning helps clinicians better understand those individual differences before developing a treatment approach.
PTSD
Living with post-traumatic stress disorder can affect emotional regulation, memory, concentration, and everyday functioning.
According to the U.S. Department of Veterans Affairs National Center for PTSD, effective treatment often begins with a comprehensive evaluation to better understand each person’s symptoms and experiences.
At Neurotherapeutix, individualized treatment planning considers the patient’s clinical history alongside advanced functional imaging to help guide care.
Although these are among the most common conditions treated, every recommendation is based on each individual’s symptoms, treatment history, and overall clinical evaluation.
How to talk to a loved one who is hesitant
Supporting someone who is reluctant to seek treatment can be challenging. While you may want to encourage them to get help, trying to persuade or pressure them often has the opposite effect.
Instead, focus on creating a conversation that feels supportive rather than convincing.
Start with curiosity instead of persuasion
Rather than telling your loved one what they should do, consider asking open-ended questions such as:
- “Can you tell me what’s making you hesitant?”
- “What concerns you most about treatment?”
- “Is there anything about previous treatments that makes you unsure about trying something new?”
Listening without immediately offering solutions helps your loved one feel heard and respected.
Acknowledge what’s already been difficult
Many people considering fMRI-guided TMS therapy have already spent months—or even years—trying medications, psychotherapy, or other interventions.
Recognizing those experiences can help your loved one feel understood. Sometimes simply acknowledging, “I know you’ve been through a lot already,” is more meaningful than trying to solve the problem right away.
Focus on learning, not committing
One of the biggest misconceptions families have is believing that scheduling a consultation means committing to treatment.
Instead, remind your loved one that an initial evaluation is an opportunity to ask questions, learn about personalized treatment options, and determine whether fMRI-guided TMS therapy may be appropriate.
Gathering information doesn’t obligate anyone to move forward.
Let them stay in control
Ultimately, treatment decisions belong to your loved one.
Your role isn’t to make the decision for them—it’s to provide encouragement, help them explore options, and remind them that support is available whenever they’re ready.
Frequently asked questions
Is brain mapping the same as standard TMS therapy?
No. Standard TMS therapy typically uses standardized anatomical landmarks to identify treatment locations.
At Neurotherapeutix, patented computational brain mapping uses resting-state functional MRI to evaluate each patient’s unique brain connectivity before treatment planning begins, allowing for a more personalized approach.
Does my loved one need a referral to get started?
No. Patients can schedule a consultation directly. During the initial evaluation, the clinical team reviews symptoms, medical history, prior treatments, and treatment goals to determine whether fMRI-guided TMS therapy is appropriate.
What if they’ve tried treatment before without success?
Previous treatment experiences don’t necessarily determine future options.
Many patients who seek care at Neurotherapeutix have tried medications, psychotherapy, or other interventions before exploring personalized brain-based treatment.
Every recommendation is individualized based on a comprehensive clinical evaluation.
Does insurance cover this treatment?
Neurotherapeutix is a private-pay practice. While the clinic does not communicate directly with insurance companies, patients who choose to pursue out-of-network reimbursement may receive superbills and supporting documentation to submit independently. The clinical team can also answer questions about the evaluation process and associated costs during your consultation.
Helping your loved one take the first step
Watching someone you care about struggle with their mental health or a neurological condition can leave you feeling helpless. While you can’t make the decision for them, you can offer support, understanding, and reliable information as they consider their options.
Sometimes the hardest part isn’t beginning treatment—it’s taking the first step toward learning what’s possible.
If your loved one is ready to explore a more personalized approach, Neurotherapeutix is here to answer your questions and explain how individualized treatment planning may fit their unique needs.
To get started, request an appointment to begin the conversation with our clinical team.
